Evidence map›Paper›PMID 36965153›Full record

ReviewThoracic cancer2023

A case of mediastinal mesenchymal tumor with pericytic neoplasm feature that responded to radiation therapy.

Miho Muramoto, Shintaro Kanda, Takashi Kobayashi, Hisashi Tamada, Ayumu Fukazawa, Keiichirou Koiwai, Tomonobu Koizumi

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in Thoracic cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Miho MuramotoDepartment of Respiratory Medicine, Nagano Matsushiro General Hospital, Nagano, Japan.ORCID 0000-0003-2114-0013
Shintaro KandaDepartment of Hematology and Medical Oncology, Shinshu University Graduate School of Medicine School of Medicine, Nagano, Japan.ORCID 0000-0001-7864-3928
Takashi KobayashiDepartment of Hematology and Medical Oncology, Shinshu University Graduate School of Medicine School of Medicine, Nagano, Japan.
Hisashi TamadaDepartment of Laboratory Medicine, Shinshu University Graduate School of Medicine School of Medicine, Nagano, Japan.
Ayumu FukazawaDepartment of Radiology, Shinshu University Graduate School of Medicine School of Medicine, Nagano, Japan.
Keiichirou KoiwaiDepartment of Radiology, Shinshu University Graduate School of Medicine School of Medicine, Nagano, Japan.
Tomonobu KoizumiDepartment of Hematology and Medical Oncology, Shinshu University Graduate School of Medicine School of Medicine, Nagano, Japan.ORCID 0000-0002-5182-0960
Shinshu University · JPNagano Matsushiro General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we report a case of mediastinal mesenchymal tumor with a pericytic neoplasm feature that responded to radiation therapy. A 43-year-old man visited our hospital with a complaint of esophageal obstruction and chest pain. Chest computed tomography revealed a middle mediastinal tumor and a mesenchymal tumor was diagnosed with a pericytic neoplasm feature by video-assisted thoracoscopic biopsy. The definitive treatment for soft tissue tumor is surgical resection; however, the mediastinal tumor was unresectable because of esophageal and tracheal invasion. Radiation therapy was administered and there was a partial tumor response and 2 years disease-free status. With a review of the literature, we discuss the clinical and pathological characteristics of this rare tumor and its treatment.

Indexed as

Mediastinal NeoplasmsAdultBiopsyHumansMaleMediastinumThoracoscopyTracheaimmunohistologymediastinal mesenchymal tumorpericytic tumorradiation therapy

Identifiers

PMID36965153
PMCPMC10151134
OpenAlexW4360946242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.